A Phase II Study Of Troxatyl [troxacitabine] In Patients With CML [chronic myelogenous leukaemia] Blastic Phase Disease.
Phase of Trial: Phase II
Latest Information Update: 10 May 2013
At a glance
- Drugs Troxacitabine (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 10 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Sep 2005 New trial record.